Home LiteratureArticle Details
PMID: 9119450 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates.

Infection and immunity ·Vol. 65 ·No. 4 ·1997-04-00 ·Pages 1189-95

Rhoades ER, Orme IM

Abstract

Murine bone marrow-derived macrophages were infected with a panel of virulent isolates of Mycobacterium tuberculosis including laboratory strains Erdman and H37Rv and various clinical isolates in order to determine the sensitivity of each of these strains to the antimycobacterial activities of macrophage-generated reactive nitrogen intermediates (RNI). All of the M. tuberculosis strains grew in murine bone marrow-derived macrophages; however, gamma interferon-primed macrophages limited the initial growth of intracellular bacilli. Some of the mycobacterial strains, including Erdman, were killed over the first 4 days of infection, as evidenced by significant decreases in the number of viable intracellular bacilli determined by a CFU assay. Other mycobacterial strains were not killed during this same period, and some isolates, including CSU 24 and CSU 31, grew steadily in activated macrophages. The accumulation of nitrite on infected monolayers was measured, and it was found that inhibitory levels of RNI did not vary among infections with the different strains. Nitrite tolerance was determined in a cell-free system for each of the strains in order to compare susceptibilities of the strains to RNI. All of the strains tested were killed by levels of RNI generated by the acidification of 10 mM NaNO2 to pH 6.5 or 5.5, and the strains exhibited a range of tolerance to lower concentrations of RNI. No correlations were observed between such cell-free RNI tolerances and the capacity of bacilli to resist macrophage RNI-mediated killing. These results indicate that under stringent conditions, RNI can kill M. tuberculosis, but that under less harsh, more physiological conditions, the effects of RNI range from partial to negligible inhibition.

MeSH Terms
Animals Drug Resistance, Microbial Macrophages/metabolism,microbiology Mice Mycobacterium tuberculosis/drug effects,genetics Nitrogen Compounds/metabolism,pharmacology Species Specificity
Chemicals
Nitrogen Compounds
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rhoades E R
Department of Microbiology, Colorado State University, Fort Collins 80523, USA. [email protected]
Orme I M
References (55)
55 references, click to expand
  1. Differentiation of mycobacteria by susceptibility to nitrite and propylene glycol.
    Am Rev Respir Dis. 1968 Sep;98(3):505-6 PMID: 5673105
  2. Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages.
    Infect Immun. 1988 Jun;56(6):1464-9 PMID: 2453466
  3. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
    J Exp Med. 1989 May 1;169(5):1543-55 PMID: 2497225
  4. Enhancement of growth of Mycobacterium lepraemurium in macrophages by gamma interferon.
    Infect Immun. 1989 Aug;57(8):2586-7 PMID: 2501220
  5. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine.
    J Immunol. 1990 Apr 1;144(7):2725-9 PMID: 2319133
  6. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.
    J Immunol. 1990 Jun 15;144(12):4794-7 PMID: 2351828
  7. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.
    J Leukoc Biol. 1990 Jul;48(1):67-73 PMID: 2113563
  8. Strain- and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon-gamma.
    J Infect Dis. 1990 Oct;162(4):932-8 PMID: 2152242
  9. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    J Leukoc Biol. 1991 Apr;49(4):380-7 PMID: 1900522
  10. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.
    Infect Immun. 1991 May;59(5):1823-31 PMID: 1902198
  11. Inactivation of macrophage nitric oxide synthase activity by NG-methyl-L-arginine.
    Biochem Biophys Res Commun. 1991 Jun 14;177(2):828-33 PMID: 2049105
  12. Role of nitric oxide synthesis in macrophage antimicrobial activity.
    Curr Opin Immunol. 1991 Feb;3(1):65-70 PMID: 1711326
  13. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens.
    J Leukoc Biol. 1991 Jul;50(1):93-103 PMID: 2056250
  14. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates.
    Cell Immunol. 1991 Jan;132(1):150-7 PMID: 1905984
  15. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.
    Infect Immun. 1991 Sep;59(9):3213-8 PMID: 1908829
  16. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.
    J Immunol. 1991 Sep 1;147(5):1642-6 PMID: 1880420
  17. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.
    J Immunol. 1992 Mar 15;148(6):1829-34 PMID: 1541823
  18. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
    J Exp Med. 1992 Apr 1;175(4):1111-22 PMID: 1552282
  19. Nitric oxide as a secretory product of mammalian cells.
    FASEB J. 1992 Sep;6(12):3051-64 PMID: 1381691
  20. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide.
    Clin Exp Immunol. 1993 Feb;91(2):277-81 PMID: 8428392
  21. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis.
    Infect Immun. 1993 May;61(5):1980-9 PMID: 8386705
  22. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.
    J Exp Med. 1993 Jun 1;177(6):1779-84 PMID: 7684434
  23. T cell response to Mycobacterium tuberculosis.
    J Infect Dis. 1993 Jun;167(6):1481-97 PMID: 8501346
  24. 'Footprinting' proteins on DNA with peroxonitrous acid.
    Nucleic Acids Res. 1993 May 25;21(10):2473-8 PMID: 8389444
  25. Nitric oxide synthase structure and mechanism.
    J Biol Chem. 1993 Jun 15;268(17):12231-4 PMID: 7685338
  26. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.
    J Immunol. 1993 Jul 1;151(1):322-9 PMID: 7686939
  27. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.
    Immunology. 1993 Nov;80(3):352-9 PMID: 8288311
  28. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase.
    Science. 1994 Feb 4;263(5147):678-81 PMID: 8303277
  29. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide.
    J Immunol. 1994 Apr 15;152(8):4110-8 PMID: 7511667
  30. Regulation of biosynthesis of nitric oxide.
    J Biol Chem. 1994 May 13;269(19):13725-8 PMID: 7514592
  31. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10.
    Int Immunol. 1994 May;6(5):693-700 PMID: 8080840
  32. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro.
    Infect Immun. 1994 Nov;62(11):5187-90 PMID: 7927804
  33. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice.
    Infect Immun. 1995 Feb;63(2):741-3 PMID: 7822053
  34. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens.
    Immunol Lett. 1994 Dec;43(1-2):87-94 PMID: 7537721
  35. Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.
    Immunology. 1995 May;85(1):106-13 PMID: 7543444
  36. Chemokine response in mice infected with Mycobacterium tuberculosis.
    Infect Immun. 1995 Oct;63(10):3871-7 PMID: 7558294
  37. The protective immune response to Mycobacterium tuberculosis.
    Curr Opin Immunol. 1995 Aug;7(4):512-6 PMID: 7495515
  38. Intracellular fate of Mycobacterium avium: use of dual-label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interaction.
    Infect Immun. 1996 Jan;64(1):319-25 PMID: 8557358
  39. Nitric oxide.
    Ann Rheum Dis. 1996 Jan;55(1):7-20 PMID: 8572740
  40. The effect of nitric oxide on bacteria.
    Appl Microbiol. 1962 May;10:185-9 PMID: 13911227
  41. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes.
    J Exp Med. 1971 Sep 1;134(3 Pt 1):713-40 PMID: 15776571
  42. Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis.
    Br J Exp Pathol. 1982 Dec;63(6):693-700 PMID: 6817780
  43. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    J Immunol. 1983 Sep;131(3):1452-4 PMID: 6411817
  44. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.
    Infect Immun. 1985 Oct;50(1):1-8 PMID: 3930401
  45. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.
    Infect Immun. 1986 Apr;52(1):252-62 PMID: 2870027
  46. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.
    Immunology. 1986 Nov;59(3):333-8 PMID: 3098676
  47. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.
    J Immunol. 1987 Jun 15;138(12):4408-13 PMID: 3108389
  48. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes.
    J Immunol. 1987 Jun 15;138(12):4414-8 PMID: 3495592
  49. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
    J Immunol. 1987 Jul 15;139(2):518-25 PMID: 3110273
  50. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    J Immunol. 1988 May 1;140(9):3006-13 PMID: 2834450
  51. Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis.
    Infect Immun. 1974 Oct;10(4):742-6 PMID: 4214780
  52. Growth inhibition of mycobacterium tuberculosis by oleate in acidified medium.
    Med Lab Technol. 1975 Jul;32(3):229-32 PMID: 240119
  53. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis.
    J Gen Microbiol. 1978 Jan;104(1):37-45 PMID: 24084
  54. Bacterial inhibitory effects of nitrite: inhibition of active transport, but not of group translocation, and of intracellular enzymes.
    Appl Environ Microbiol. 1980 Apr;39(4):831-4 PMID: 6769392
  55. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide.
    J Exp Med. 1989 Mar 1;169(3):1011-20 PMID: 2784476
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1997-04-00
Pages
1189-95
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC175116
Subset
IM
Grants
NIAID NIH HHS · AI-25147 · United States
NIAID NIH HHS · AI-40488 · United States
NHLBI NIH HHS · HL-55936 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]